FCGR3A and lung carcinoma: However, higher expression of FCGR3A and IFNG in lung carcinoma patients exhibits shorter survival time with hazard ratio and 95% confident interval of 1.50 (1.32-1.71) and 1.15 (1.02-1.31), respectively.